Factors that predict outcome of abdominal operations in patients with advanced cirrhosis

Dana A Telem1, Thomas Schiano, Robert Goldstone

  • 1Division of General Surgery, Department of Surgery, The Mount Sinai Hospital, New York, New York, USA.

Insights

Cirrhotic patients face surgical risks, but preoperative albumin levels can guide operative decisions for those with high MELD scores. Limiting intraoperative blood transfusions also improves outcomes in these vulnerable patients.

Area of Science:

  • Hepatology
  • Surgical Oncology
  • Anesthesiology

Background:

  • Cirrhosis increases surgical complication risk, varying with liver disease severity.
  • Selecting optimal surgical candidates with cirrhosis presents a clinical challenge.
  • Identifying predictive factors for surgical outcomes in cirrhotic patients is crucial for management.

Purpose of the Study:

  • To identify factors aiding the selection of surgical candidates with cirrhosis.
  • To guide the perioperative management of cirrhotic patients undergoing surgery.
  • To determine predictors of adverse outcomes in cirrhotic patients undergoing abdominal surgery.

Main Methods:

  • Retrospective review of 100 cirrhotic patients (Child-Turcotte-Pugh A, B, C) undergoing abdominal surgery.
  • Analysis of patient data from 2002-2008 at a liver medicine and transplant institution.
  • Multivariate logistic regression to identify factors correlating with surgical outcomes.

Main Results:

  • Overall 30-day postoperative mortality was 7%, with higher rates for advanced cirrhosis (CTP B/C) and MELD score ≥15.
  • Risk factors for adverse outcomes included high ASA score, emergent procedures, significant blood loss/transfusion, ascites, high bilirubin, and low albumin.
  • Adding serum albumin to the MELD score significantly stratified mortality risk for patients with MELD ≥15.

Conclusions:

  • Preoperative albumin levels can refine risk assessment for cirrhotic patients with MELD scores ≥15.
  • Limiting intraoperative packed red blood cell transfusions is recommended to improve outcomes.
  • These findings can aid in operative decision-making and patient management for cirrhotic individuals.
Abstract

Related Concept Videos

Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...